BIOCOM for BIOCOM
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Asked to support additional funding for NIH, FDA, and BARDA. Asked to support the FDA SOS Act, which would exempt FDA user fees from sequestration.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
| JOE PANETTA | — |
Taxation/Internal Revenue Code TAX
Voiced support for a repeal of the medical device tax.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
| JOE PANETTA | — |
Copyright/Patent/Trademark CPT
Raised concerns with H.R.9, the Innovation Act. Expressed support for S.632, the Strong Patents Act and for reintroduction of the Trol Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
| JOE PANETTA | — |
Health Issues HCR
Expressed support for Medicare Part B and D and discussed patients' access to medicines. Discussed legislative proposals in the 21st Century Cures Initiative. Submitted comments to the Energy & Commerce Committee regarding 21st Century Cures. Discussed SBIR/STTR programs and current initiatives at the NIH.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
| JOE PANETTA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.